From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here
CRISPR TherapeuticsCRISPR Therapeutics(US:CRSP) 247Wallst·2026-03-17 16:16

FTSE 10010,410.00 +0.60% Nikkei 22554,313.90 -0.41% Stock Market Live March 17, 2026: S&P 500 (SPY) Flat as Oil Gushes Higher From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here - 24/7 Wall St. S&P 5006,726.10 +0.28% Dow Jones47,021.00 +0.18% Nasdaq 10024,789.20 +0.43% Russell 20002,513.87 +0.38% Investing From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here By Joel SouthPublished Mar 17, 12:16PM EDT Quick Read CRISPR Therapeutics (CRSP) holds $2.56B in p ...

CRISPR Therapeutics-From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here - Reportify